Tempus to acquire Personalis for $1.5 billion

TEM•2026-07-20

Tempus to acquire Personalis

July 20 (Reuters) - Tempus AI said on Monday it would acquire Personalis for about $1.5 billion to bring its cancer test to the AI-enabled precision medicine firm's oncology portfolio.

Tempus to acquire Personalis for $1.5 billion

Tempus to acquire Personalis

Related News

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000

Domino's Pizza Inc <DPZ.O>: Piper Sandler Cuts Target Price to $353 From $359

Goldman sees Brent exceeding $120/bbl in Q4 if Hormuz disruptions persist

Vita Coco Company Inc raises target price to $80 from $75

FOREX-Dollar near one-week high as markets grapple with Gulf tensions